Michael Piechocki

All Eye Drops and Eye/Ear Wash products manufactured by NuCel Labs have been voluntarily recalled by the company because of a detected compromise in their sterility, according to a press release from the U.S. Food and Drug Administration.

A U.S. Senate committee is investigating Genentech in regards to its plan to cease supplying the cancer drug bevacizumab to compounding pharmacies that repackage the drug for ophthalmic use. The plan was scheduled to take effect Jan. 1.

SANTA ANA, Calif. — The U.S. Food and Drug Administration recently approved Advanced Medical Optics’ CustomVue laser platform for performing monovision LASIK, the agency announced in a press release. This is the first laser platform to receive marketing clearance for monovision LASIK, the release said.

CHICAGO — According to a press release, Prevent Blindness America launched a new online resource for patients and visitors to educate them on eye protection.

SAN DIEGO — U.S. refractive surgeons are increasingly adopting the latest advances in surgical techniques and technology, according to a 2006 survey of members of the American Society of Cataract and Refractive Surgery.

圣地亚哥讯—据美国白内障和屈光手术学会2006的一项调查表明，美国屈光医生正越来越多地采用最新手术技术进展。

SAN DIEGO — U.S. refractive surgeons are increasingly adopting the latest advances in surgical techniques and technology, according to a 2006 survey of members of the American Society of Cataract and Refractive Surgery.

SAN DIEGO — U.S. refractive surgeons are increasingly adopting the latest advances in surgical techniques and technology, according to a 2006 survey of members of the American Society of Cataract and Refractive Surgery.

BOSTON — pSivida is selling its subsidiary, AION Diagnostics, to the portfolio management company GEM Global Yield Fund for two payments of $1.5 million, the company announced in a press release.

WALTHAM, Mass. — A combretastatin A4 phosphate drug for myopic macular degeneration prevented vision loss without serious adverse events in a phase 2 trial, according to a press release from Oxigene, the drug’s manufacturer.